Daiwa Securities Group Inc. - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 54 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.27 and the average weighting 0.0%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5
-28.6%
2,7280.0%0.00%
Q2 2023$7
+40.0%
2,7280.0%0.00%
Q1 2023$5
+66.7%
2,728
+236.8%
0.00%
Q4 2022$3810
+142.5%
0.00%
Q3 2022$03340.0%0.00%
Q2 2022$0
-100.0%
3340.0%0.00%
Q1 2022$1,0000.0%3340.0%0.00%
Q4 2021$1,000
-50.0%
3340.0%0.00%
Q3 2021$2,000
+100.0%
334
+115.5%
0.00%
Q2 2021$1,0000.0%1550.0%0.00%
Q1 2021$1,0000.0%1550.0%0.00%
Q4 2020$1,0001550.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Alpine Global Management, LLC 300,000$300,0000.08%
Polar Capital Holdings Plc 5,599,407$5,599,0000.03%
VANCE WEALTH, INC. 13,299$13,0000.01%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$39,0000.01%
BENDER ROBERT & ASSOCIATES 14,059$14,0000.01%
HoyleCohen, LLC 30,432$30,0000.00%
Inscription Capital, LLC 17,000$17,0000.00%
Ergoteles LLC 100,722$101,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 89,100$89,0000.00%
ADIRONDACK TRUST CO 2,500$3,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders